Astrana Health, Inc. $ASTH Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. decreased its position in Astrana Health, Inc. (NASDAQ:ASTH) by 10.2% in the 4th quarter, Holdings Channel.com reports. The fund owned 4,238,192 shares of the company’s stock after selling 482,884 shares during the period. Vanguard Group Inc. owned approximately 0.08% of Astrana Health worth $105,150,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in ASTH. Ameriprise Financial Inc. grew its position in shares of Astrana Health by 231.0% in the 3rd quarter. Ameriprise Financial Inc. now owns 442,314 shares of the company’s stock worth $12,540,000 after acquiring an additional 308,665 shares in the last quarter. 325 Capital LLC grew its position in shares of Astrana Health by 34.6% in the 3rd quarter. 325 Capital LLC now owns 1,193,953 shares of the company’s stock worth $33,849,000 after acquiring an additional 307,037 shares in the last quarter. Insight Wealth Strategies LLC acquired a new position in Astrana Health during the 4th quarter valued at approximately $3,514,000. Hotchkis & Wiley Capital Management LLC boosted its position in Astrana Health by 44.2% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 421,710 shares of the company’s stock valued at $11,955,000 after purchasing an additional 129,270 shares during the period. Finally, AXA S.A. acquired a new position in Astrana Health during the 2nd quarter valued at approximately $3,150,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Trading Up 2.7%

Shares of ASTH stock opened at $39.01 on Wednesday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.40 and a current ratio of 1.35. Astrana Health, Inc. has a 1 year low of $18.08 and a 1 year high of $39.90. The stock has a fifty day moving average of $28.49 and a two-hundred day moving average of $25.79. The firm has a market capitalization of $2.17 billion, a PE ratio of 63.95 and a beta of 0.98.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The company had revenue of $965.10 million during the quarter, compared to analyst estimates of $949.21 million. During the same quarter in the previous year, the firm posted $0.42 EPS. The firm’s quarterly revenue was up 55.6% on a year-over-year basis. As a group, research analysts expect that Astrana Health, Inc. will post 1.43 EPS for the current year.

Analyst Ratings Changes

A number of research firms recently issued reports on ASTH. Zacks Research upgraded Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 11th. Needham & Company LLC boosted their price objective on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Truist Financial boosted their price objective on Astrana Health from $37.00 to $38.00 and gave the company a “buy” rating in a research report on Friday, March 13th. TD Cowen boosted their price objective on Astrana Health from $35.00 to $45.00 and gave the company a “buy” rating in a research report on Tuesday. Finally, Robert W. Baird set a $45.00 price objective on Astrana Health in a research report on Friday. Six research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $41.86.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.